Epilepsy & behavior : E&BHumansMaleFemaleLennox Gastaut SyndromeChild
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.
Kelly G Knupp, Ingrid E Scheffer, An-Sofie Schoonjans, Joseph Sullivan, Lieven Lagae, Stéphane Auvin, Elizabeth A Thiele, Renzo Guerrini, Sameer M Zuberi, Rima Nabbout, Kate Riney, Katherine C Nickels, Ronald Davis, Michael D Lock, David Dai
Published: 202510.1016/j.yebeh.2025.110753
Abstract
OBJECTIVE: To describe long-term safety and effectiveness of fenfluramine in pediatric and adult patients with Lennox-Gastaut syndrome (LGS) from the final analysis of an open-label extension (OLE) study. METHODS: Patients (aged 2-35y) who participat…
Preview only. Read the full abstract at the source